Skip to content
Saturday, June 13, 2026
Latest
The Canadian Dream Is Leaving Canada | Spencer Gatten
Where’s the Beef? JBS Latest to Close Processing Plants Amid Cattle Shortage
SBF Loses Appeal, Locking in 25-Year FTX Fraud Sentence
Allied Gold: The Zijin Deal Is On The Rocks
Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth
Anthropic Suspends Fable 5 Access After US Government Export Control Order
Judge Freezes Trump’s $1.8B Anti-Weaponization Fund
Will The Real US-Iran Peace Deal Please Stand Up?
Saylor: I Said You, Not The Company, Should Never Sell Bitcoin
Lundin Gold Distributes Entire LunR Stake to Shareholders as Dividend in Kind
Search
Home
Latest
Automotive
Cannabis
Commentary
Full Analysis
Gold
Industrials
Macro
Oil
Resources
Technology
Resources
Energy
Technology
Coverage Companies
Altamira Gold
Antimony Resources
Canadian Copper
Cardiol Therapeutics
Emerita Resources
First Majestic Silver
First Phosphate
Granada Gold
McLaren Resources
Mercado Minerals
Nord Precious Metals
Power Metallic
PTX Metals
Riverside Resources
Silver47 Exploration
Steadright
About
Contact Us
Home
Latest
Automotive
Cannabis
Commentary
Full Analysis
Gold
Industrials
Macro
Oil
Resources
Technology
Resources
Energy
Technology
Coverage Companies
Altamira Gold
Antimony Resources
Canadian Copper
Cardiol Therapeutics
Emerita Resources
First Majestic Silver
First Phosphate
Granada Gold
McLaren Resources
Mercado Minerals
Nord Precious Metals
Power Metallic
PTX Metals
Riverside Resources
Silver47 Exploration
Steadright
About
Contact Us
Home
Latest
Automotive
Cannabis
Commentary
Full Analysis
Gold
Industrials
Macro
Oil
Resources
Technology
Resources
Energy
Technology
Coverage Companies
Altamira Gold
Antimony Resources
Canadian Copper
Cardiol Therapeutics
Emerita Resources
First Majestic Silver
First Phosphate
Granada Gold
McLaren Resources
Mercado Minerals
Nord Precious Metals
Power Metallic
PTX Metals
Riverside Resources
Silver47 Exploration
Steadright
About
Contact Us
Antibe Therapeutics
Canaccord Drops Antibe’s Price Target To $0.70 Following Asset Sale
July 15, 2022, 02:25:00 PM
Read More
Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot
October 18, 2021, 11:31:00 AM
Read More
Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused
September 29, 2021, 11:44:00 AM
Read More
Antibe Therapeutics Pauses Otenaproxesul Trial After Exceeding Safety Threshold
August 3, 2021, 09:50:31 AM
Read More
Antibe: Canaccord Raises Price Target After Q4 Results
July 2, 2021, 12:18:00 PM
Read More
Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing
February 26, 2021, 11:55:00 AM
Read More
Antibe Therapeutics To Raise $35.1 Million In Bought Deal
February 18, 2021, 07:30:48 AM
Read More
Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50
February 11, 2021, 04:07:00 PM
Read More
Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target
August 18, 2020, 01:46:28 PM
Read More
Antibe Therapeutics Proposes Share Consolidation To Enable Potential Nasdaq Listing
July 15, 2020, 10:04:38 PM
Read More
Previous
Page
1
Page
2
Next
Latest News
The Canadian Dream Is Leaving Canada | Spencer Gatten
Where’s the Beef? JBS Latest to Close Processing Plants Amid Cattle Shortage
SBF Loses Appeal, Locking in 25-Year FTX Fraud Sentence
Allied Gold: The Zijin Deal Is On The Rocks
Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth
Anthropic Suspends Fable 5 Access After US Government Export Control Order
Judge Freezes Trump’s $1.8B Anti-Weaponization Fund
Will The Real US-Iran Peace Deal Please Stand Up?
Saylor: I Said You, Not The Company, Should Never Sell Bitcoin
Lundin Gold Distributes Entire LunR Stake to Shareholders as Dividend in Kind
Video Articles
The Canadian Dream Is Leaving Canada | Spencer Gatten
Allied Gold: The Zijin Deal Is On The Rocks
Why Silver’s Drop May Not Mean the Bull Market Is Over | Peter Krauth
Recommended
Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project
Blue Jay Gold Launches 16,000 Metre Drill Program At Steller
Trending
Sorry, Andrew Tate Is Not a Legitimate Military Target—Ukraine's Drone Forces Explain
Leonardo’s SignalTrace Could Let Police Plate Readers Track Your Devices
Saylor: I Said You, Not The Company, Should Never Sell Bitcoin
Trans Mountain Hits Full Capacity for the First Time as Hormuz Crisis Drives Asian Demand for Canadian Oil
Anthropic Suspends Fable 5 Access After US Government Export Control Order
Bezos Warns AI Could Trigger A Labor Shortage
A One-Million-Square-Foot Medical Warehouse Just Burned to the Ground—With Non-Functional Sprinklers
[UPDATED] BYD Eyes Canadian Market as Trade Deal Opens Door to Chinese EVs
OpenAI Bolsters Coding Assistant with Acquisition of Cloud Startup Ona
US and Iran Have Agreed on Deal Text, Mediator Says—But Final Sign-Off Still Pending
Search
